Analytical Data
-
Gene name
CTSA
- Application
-
Alternative Names
CTSA；PPGB；Lysosomal protective Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P10619
-
Expression Region
29-480aa
-
AA Sequence
AP DQDEIQRLPG LAKQPSFRQY SGYLKGSGSK HLHYWFVESQ KDPENSPVVL WLNGGPGCSS LDGLLTEHGP FLVQPDGVTL EYNPYSWNLI ANVLYLESPA GVGFSYSDDK FYATNDTEVA QSNFEALQDF FRLFPEYKNN KLFLTGESYA GIYIPTLAVL VMQDPSMNLQ GLAVGNGLSS YEQNDNSLVY FAYYHGLLGN RLWSSLQTHC CSQNKCNFYD NKDLECVTNL QEVARIVGNS GLNIYNLYAP CAGGVPSHFR YEKDTVVVQD LGNIFTRLPL KRMWHQALLR SGDKVRMDPP CTNTTAASTY LNNPYVRKAL NIPEQLPQWD MCNFLVNLQY RRLYRSMNSQ YLKLLSSQKY QILLYNGDVD MACNFMGDEW FVDSLNQKME VQRRPWLVKY GDSGEQIAGF VKEFSHIAFL TIKGAGHMVP TDKPLAAFTM FSRFLNKQPY
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTSA (Carbohydrate Transporter and Signal Antibody) is a crucial protein involved in various biological processes, particularly in the transport and metabolism of carbohydrates within cells. It plays a significant role in cellular signaling pathways and regulation of energy homeostasis. Research on CTSA recombinant proteins has gained momentum due to the increasing understanding of its implications in metabolic disorders, such as diabetes and obesity, and its potential in cancer biology. As CTSA is implicated in glucose uptake and insulin sensitivity, scientists aim to elucidate its structural and functional properties to explore therapeutic avenues for these conditions. Furthermore, recombinant CTSA proteins can be utilized in developing monoclonal antibodies for diagnostic and therapeutic applications. The advancement in recombinant protein technology has enabled the production of high yields of CTSA, allowing detailed studies of its interactions with substrates and inhibitors, thereby paving the way for innovative treatment strategies and improving our understanding of carbohydrate metabolism at the molecular level. By investigating the recombined CTSA in various model systems, researchers hope to establish its functional relevance and therapeutic potential, ultimately leading to improved management of metabolic diseases and enhanced therapeutic outcomes.
